RECRUITING

Coenzyme Q10 for Gulf War Illness: A Replication Study

Description

The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.

Conditions

Gulf War SyndromePersian Gulf SyndromeMitochondrial Disorder, Respiratory Chain
Talk to us

Related Conditions:

Gulf War SyndromePersian Gulf SyndromeMitochondrial Disorder, Respiratory Chain

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.

Coenzyme Q10 for Gulf War Illness: A Replication Study

Coenzyme Q10 for Gulf War Illness: A Replication Study

Condition
Gulf War Syndrome
Intervention / Treatment

-

Contacts and Locations

La Jolla

UC San Diego, La Jolla, California, United States, 92093

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Meets both CDC and Kansas deployment and symptom inclusion criteria.
  • * Does not have a disqualifying condition.
  • * Able to travel to a local Quest facility for study blood draws.
  • * Adequate internet access to allow ZoomPro visit participation and remote survey completion.
  • * Health prior to the Gulf War rated as "very good" or "excellent" (to exclude persons who may have had other health conditions with different mechanisms as the cause of their symptoms).
  • * Willing to defer initiation of discretionary treatments or supplements during the expected course of study participation.
  • * Participating in another clinical trial.
  • * Still-evolving adverse effects following another medication or health condition, such as covid or fluoroquinolone use.
  • * On Coumadin/ warfarin.
  • * Unable to participate for the required duration of the study.

Ages Eligible for Study

50 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Diego,

Beatrice A Golomb, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Diego

Study Record Dates

2027-12